SCHEMBL14033465

SCHEMBL14033465

OC(c1ccc(Cl)cc1)c1cn[nH]c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKT2 P31751 5/20 0.46
CYP19A1 P11511 1/20 0.46
AKT1 P31749 10/20 0.44
PRKCD Q05655 2/20 0.43
PRKD3 O94806 1/20 0.43
PRKCG P05129 1/20 0.43
PRKCB P05771 1/20 0.43
BRAF P15056 1/20 0.43
PRKCA P17252 1/20 0.43
PRKCH P24723 1/20 0.43
PRKCI P41743 1/20 0.43
PRKCE Q02156 1/20 0.43
PRKCQ Q04759 1/20 0.43
PRKCZ Q05513 1/20 0.43
PRKD1 Q15139 1/20 0.43
ROCK2 O75116 5/20 0.42
PRKACA P17612 2/20 0.38
AKT3 Q9Y243 2/20 0.38
RPS6KA5 O75582 1/20 0.38
RPS6KA4 O75676 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6532251 0.81 SMN1; SMN2 (0.50) AKT2AKT1ROCK2ROCK1
SCHEMBL14033960 0.79 AKT2 (0.51) AKT2CYP19A1AKT1PRKCDPRKD3
SCHEMBL1426754 0.77 TSHR (0.50) CYP19A1
SCHEMBL2912058 0.71 CYP19A1 (0.64) CYP19A1
SCHEMBL2907043 0.70 CYP19A1 (0.68) CYP19A1AKT1
SCHEMBL3299158 0.69 KCNQ3 (0.41) CYP19A1
SCHEMBL477379 0.69 IDO1 (0.54)
SCHEMBL477349 0.69 IDO1 (0.54)
SCHEMBL14033378 0.69 CYP17A1 (0.52) CYP19A1
SCHEMBL477552 0.69 IDO1 (0.54)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7432268-B2 17β-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases SCHERING CORPORATION (US) 2008-10-07 US disclosed
US-7432268-B2 17β-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases SCHERING CORPORATION (US) 2008-10-07 US disclosed
EP-1423381-B1 17BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 3 INHIBITORS FOR THE TREATMENT OF ANDROGEN DEPENDENT DISEASES SCHERING CORP (US) 2007-01-03 EP disclosed